FTC sues major pharmacy gain professionals about insulin prices The company brought action against Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the list cost of lifetime-conserving insulin medication. Insurers will carry on vertically integrating to maintain additional income in-property, and federal sc... https://busch-light-peach-nutriti50494.bloggazza.com/29928491/details-fiction-and-healthcare-news